chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sweating; fever; chills; headache; body aches; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), PYREXIA (fever), CHILLS (chills), HEADACHE (headache) and PAIN (body aches) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 027L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On 08-Feb-2021, the patient experienced HYPERHIDROSIS (sweating), PYREXIA (fever), CHILLS (chills), HEADACHE (headache) and PAIN (body aches). At the time of the report, HYPERHIDROSIS (sweating), PYREXIA (fever), CHILLS (chills), HEADACHE (headache) and PAIN (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Reporter did not allow further contact
erythematous raised wheel-non tender pruritic- 8x10 cm with central induration 2 cm at vaccine site
A physician reported that a child received a third dose of Prevnar and subsequently developed Stretpococcus pneumoniae meningitis. A blood culture was positive. A lumbar puncture revealed 180 white blood cells and no bacteria. Treatment with ceftriaxone had commenced two days prior to lumbar puncture. This event is considered medically important. Follow up information received on 03 MAY 2002 indicated that the child is a 19 month old male. On 27 JUN 2001, at 10 months of age, he received his third dose of Prevnar. On 20 APR 2002, developed Streptococcus pneumoniae meningitis and on 21 APR 2002, he was hospitalized. A blood culture was positive for Streptococcus pneumoniae (serotype unknown). Follow up information received on 13 MAY 2002 indicated that the Streptococcal pneumoniae isolate was non typable because it did not react with the antisera. The reporter indicated that ribotyping will be done for this isolate. Follow up information received on 17 MAY 2002 indicated that lab tests revealed an IgG of 1050 mg/dl, an IgA of 173 mg/dL, and an IgM of 144 mg/dL. Follow up information received on 28 may 2002 indicated that he was discharged after 14 days. He recovered.
This spontaneous report was received from the patient's mother, who referred to a female patient of unknown age. The patient had no allergies. No information regarding the patient's pertinent medical history and concomitant therapies was provided. On 17-JUL-2016, the patient was administered with a first dose GARDASIL 9 (dose, route of administration, lot # and expiration date was not reported) as prophylaxis. The patient completed the series of 3 doses of the vaccine (2nd and 3rd doses were administered on unknown dates). On 17-JUL-2016, also reported as on an unspecified date, the patient experienced hair loss for an unspecified reason. The outcome of the reported event was unknown. No product quality complaint was involved. The relatedness between the event and the suspect therapy was not reported. Additional information is not expected as the patient declined consent for further contact.
Patient felt tired and dizzy a few minutes after vaccine (didn't completely faint). I asked her to lay down on her back and elevate her legs on the chair. she started to feel a lot better. She decided to sit up and I gave her some water. I monitored her until she regained full energy and felt back to 100% normal
Pharmacist who administered COVID-19 vaccine documented Pfizer Lot #FK5127 was administered and this is what was recorded in Database; however, the COVID-19 vaccination card the parent/patient received had Moderna Lot #065F21A listed.  Parent (who also is a nurse) noticed this discrepancy and when she asked the pharmacist about it he indicated the patient did receive the Pfizer product and that the information on the card was done "by muscle memory". Parent is concerned about which product the patient actually received - Pfizer/BioNTech is the only product currently authorized by the FDA for this child's age group (5-11 years).
The mother of a 5 year old female reported that her daughter received Prevnar, MMR (Merck), IPV (Aventis Pasteur SA) and DTP vaccines on 8/3/00. The next day, she developed a fever, headache and a rash at the Prevnar injection site. She vomited on 8/5/00. As of 8/11/00, the mother reported that the child was improving.
Feverish (101) and vomiting every night for 5 days. Fussing and crying through the night. Lethargic and low appetite during the days. Red pinprick rash on back on 3/4th day. Mood picked up after 5th day.
She got her vaccine, left there, went to the store and her arm was a little bit sore, which she was told it might be.  She went home, got really really tired and went to bed, slept all night long.  When she woke up she couldn't talk, could not get out of bed, felt really sick and tired.  When she finally woke up completely she could not talk and she could not use the phone.  She finally got out of bed at 9:00 PM the following evening.  She had trouble walking, like she had a stroke.  She tried to use the phone to call a neighbor as well and could not use it.   Daughter states that she tried to text her and it did not make any sense.  She went outside, grabbed onto things to be able to reach the neighbor.  Got there and pulled herself up her steps (neighbor claims she scratched on the screen door, and she did not remember that).  She could not talk to the neighbor who called 9-1-1 and she could not go back down the steps, and they put her on a gurney, she remembers hearing the siren but does not remember anything after that.  She was taken to the hospital and thought she was having a stroke.  She had an MRI (she does not remember it), could not find anything wrong.  They called her daughter who works at the hospital and she was there when she arrived.  She does not remember a whole lot of what happened, but she remembers feeling really sick to her stomach and her daughter said that she was throwing up (she does not remember that), she also felt like she was having a seizure, and could not control her right leg.  They did some EEG's on her, they put her in the stroke unit for 2 days.  They also had PT/OT coming in to help her get to the bathroom and assist with walking.  They also did another MRI and could not find anything wrong with her.  They said that since she had the vaccine they thought it was possibly due to the vaccine, which the daughter informed them that she had had.  Her daughter spent the night with her in the hospital  was having trouble talking and then within 3-4 days while in the hospital she was able to talk again.  She was then sent home.  She was then walking, talking and was back to her normal state prior to the vaccine.    She went to see her doctor a week later and she explained what had happened and agreed that it was due to the vaccine.  She does still have some trouble still with her arm, just feels like the vaccine really screwed her up.   Her daughter is a pharmacy tech in the hospital who checked with colleagues who told her to report to us.    Sometimes when she wakes up she has trouble swallowing, like a panic attack.  She continues to have them periodically.  She did not have these problems prior to that.  She did not have problems like that with the 1st vaccine, she felt a little weird with the first one, but nothing otherwise.
Developed classic shingles rash (R) mid chest on 11/21. Two days after receiving vaccine (L) arm.
contracted tetanus-convuls, dislocation of shoulders #18- fractured rt shoulder-shoulder replacement
Circle Rashes on both breast approximately 1 1/2 in size, Welts Rash under bothbreast, large welts on stomach, rash on left arm at injection site, headaches.  Tylenol and Benedryl taken every day and scars and peeling skin on both breast forming where rashes are.
Dose 1 COVID pfizer vaccine given 2/24/21, dose 2 COVID Pfizer vaccine given 3/17/21.  Patient hospitalized 11/10/21 with respiratory failure.  still hospitalized today 11/11/21, and D/C not expected soon.
Pt states that a couple hours after receiving the vaccine she felt lethargic/tired, headache, nausea, chills, fever, muscle pain, and sore arm. She also states that there was a red circle around the injection site and some swelling. Symptoms persisted for a few days and she developed nasal congestion, ear aches, and loss of sense of taste and smell. Also had numbness in shoulder down to her pinky for a short period of time.
I have been itching and hot, hot UNDER my skin since receiving this first vaccine. I find it hard to breathe but have no lung issues. It makes me feel anxious. I've become spastic at times. Really clumsy. But the hot flushing hands, arms and body symptoms are hard to deal with. I've seen 8 specialists and none have answers. It does seem to have been triggered by my first vaccine injection. And has gotten worse with more vaccines and boosters.
Facial Numbness that migrated to neck and arm.  Later (13 days)became widespread after discharge.
Right after vaccine, she feel like she is having trouble breathing, her lips feels like swelling and her tongue swelling, then I gave her EPIPEN and call 911 then few minutes after she said she feels better now, no hives, no dizziness as well, she was able to  talk, walk and drink water as well.
A report was received from a health professional on 25Oct02, concerning seven vaccinees who experienced red, burning, hard nodules at the site of injection, after receiving Fluvirin on 22Oct02. On 22Oct02, seven out of 68 employees who received Fluvirin at a community hospital experienced red, burning, hard nodules at the site of injection within a few hours. The vaccinees were seen in the ER. The vaccine was administered using a TB syringe with a prefixed needle. It was unk if the vaccinees recovered. The reporter suspects that these adverse effects are probably associated with this particular batch of Fluvirin. The following day, additional employees received Fluvirin from a different batch and no adverse effects were noted. Update 1 20Feb03: A report was received from health care professional concerning a vaccinee of unk demography who experienced raised red, induration at the injection site 15 min after receiving Fluvirin on an unk date. The vaccinee had recovered at the time of the report. Three other vaccinees had the same reaction to the same batch. There was insufficient information to determine the reporters causality assessment. See Ref: PJP200200541, PJP20030088, PJP200300090.
His grandmother received the Pfizer COVID 19 vaccine and died 3 days later; This is a spontaneous report from a contactable consumer or other non-healthcare professional (reporter's grandson reported for his grandmother). A 71-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced that his grandmother received the Pfizer COVID 19 vaccine and died 3 days later. It was reported that caller's grandmother who was 71-year-old received the Pfizer COVID 19 vaccine and died 3 days later. He wanted to talk to medical information department about why there was no FDA information on the boxes about who is liable before he gets the vaccine. He worked in the medical field but was not a medical professional and he has seen the packaging there was just a QR code and a fact sheet. His questions are one, he has to sign a form before he gets the vaccine. He has a lawyer, and they said its still under emergency use. His lawyer was saying that the company he works for was not liable if anything happens. He was a single father with two kids. His question was after seeing on the news that said its 100% approved but the lawyer was saying it was not. Other countries are saying it was not even a pandemic. He has to weigh out the pros and cons and he wants to know if it's safe. Product quality complaint was reported as yes. The patient died on an unspecified date. It was not reported if an autopsy was performed.  Follow-up activities closed. Batch/lot number not available for [vaccine/BNT162B2].; Reported Cause(s) of Death: His grandmother received the Pfizer COVID 19 vaccine and died 3 days later
pt recv vax & exp pain & stiffness in the lt side of neck; No further details were provided;
FLUZONE given 1230 c/o "lips numb", progressing to "chest tightness" 1238 (no rash or hypotension, no wheezing) EPI given 1240. EMS called.
got the 2nd dose yesterday (26Mar2021) and tested positive for covid-19 today (27Mar2021); got the 2nd dose yesterday (26Mar2021) and tested positive for covid-19 today (27Mar2021); This is a spontaneous report from a Pfizer-sponsored program. This contactable consumer (parent) reporting the same events under the same suspect product for 2 patients. This is one of 2 reports.   A male patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 26Mar2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient got the 2nd dose yesterday (26Mar2021) and tested positive for covid-19 today (27Mar2021). Outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021359549 Same reporter, product and event, and different patient
Pt recvd vax 8AUG91 & on 9SEP91 pt exp episode of presyncope & garbled speech, & was hospitalized; condition was dx as post-vaccination transverse myelitis;
arm  welts; arm  warmth to touch; arm  tenderness; This case was reported by a pharmacist via call center representative and described the occurrence of welts in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th May 2019, the patient received the 1st dose of Shingrix. In May 2019, less than a week after receiving Shingrix, the patient experienced welts, skin warm and pain in arm. On an unknown date, the outcome of the welts, skin warm and pain in arm were recovering/resolving.   It was unknown if the reporter considered the welts, skin warm and pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient experienced welts on her arm, and her arm was warm and tender to the touch after receiving Shingrix. On 22nd May 2019, the patient went to see her doctor for treatment of welts, warmth, and tenderness. The welts, warmth, and tenderness were improving, but had not resolved. On 21st May 2019, the patient was in bed all day, the day after she received the vaccine. The healthcare professional did not have lot number or expiration date to provide. This case has been linked with US2019092213, reported by same reporter.
Patient had Pfizer vaccine 6/30/2021 and 7/21/2021 Has no side effects to 1st dose of covid-19 vaccine 3 days after having 2nd dose of vaccine, reports back pain which lasted 2 weeks Also had itchy sensation on face and arms, but no rash
Patient slumped in chair, very faint, pale, sweaty, light headed and clammy. Looked like having a seizures ( but wasn't ) with arms up. Gave Epi-pen and called 911. EMTs came and evaluated patient and he left about 30 to 45 minutes later ok. Patient appeared to have recovered from adverse reaction, will check on patient 4/6/21
Following the injection (the next day), the patient broke out in hives and was itchy for about 2 1/2 -3 days. I gave her Benadryl to relieve the symptoms. She was not seen by the doctor. the hives went away after about 3 days.
Pt received ZOSTAVAX on 2-17-14 broke out with rash over right temple on 2-20-14, reported event to pharmacy on 2-22-14 pt said it is improving.
Started developing tinnitus/ continued to get worse 5 1/2 months out sounds like constant electrical buzz in center of back of the head; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 26Mar2021 at 14:45 (at the age of 61-years-old) as a single dose for COVID-19 immunization. The patient had no medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 05Mar2021 at 14:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. On 29Mar2021, the patient started developing tinnitus within few days of the second (2nd) shot. The patient had visited an ENT (Ear nose throat) and the doctor said that structurally everything was fine. The doctor had seen a great uptick in tinnitus for patients after the vaccine. The tinnitus had continued to get worse 5 and a half (1/2) months out and sounds like a constant electrical buzz in the center of the back of the head. It never went away, so loud that the patient heard it over television (TV), fans, etc. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had been tested for COVID-19. The patient underwent a COVID-19 test (reported as blood test) on 17Mar2021, 12May2021, and 07Jul2021 and the result was negative. The patient also underwent a rapid test via nasal swab on 03Sep2021 and the result was negative. The clinical outcome of the event started developing tinnitus/ continued to get worse 5 1/2 months out sounds like constant electrical buzz in center of back of the head was not resolved at the time of the report.
48 hours after vaccine, half of my right eye (right side of pupil) turned red. No itching, no watering, no pain, no effect on eye sight. It remained red for 72 hours. Used Clear eyes drops once a day; This is a spontaneous report from a contactable consumer, the patient. A 59-years-old male patient received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: ER8733), via an unspecified route of administration in the left arm on 29Mar2021 at 13:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, since an unspecified date of 2020 (last year) (140-90). Concomitant medications included lisinopril/hydrochlorothiazide (MANUFACTURER UNKNOWN) taken for blood pressure and unknown if ongoing. The patient had no allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 31Mar2021 at 13:00, 48 hours after the vaccination, the patient experienced half of the right eye (right side of the pupil) turned red. No itching, no watering, no pain, no effect on eyesight. It remained red for 72 hours. The treatment included Clear eyes drops once a day for the reported event. The clinical outcome of the event half of the right eye (right side of the pupil) turned red was recovered on 03Apr2021, after the duration of 72 hours.  No follow-up attempts are needed. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported: updated age at vaccination, medical history data and event data.
Heart palpitation, mild shortness of breath, chest discomfort  Palpitation was roughly one week after the shot Symptoms began slightly before one week after the vaccine and have become more mild over 2.5 weeks
Felt like she was having a heart attack; Had pressure from chest down to her stomach; A spontaneous report was received from a consumer concerning herself, a 60-year-old patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and she felt like she was having a heart attack / myocardial infraction and had pressure from chest down to her stomach / chest discomfort.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 17 Mar 2021, approximately six days prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch number: unknown) intramuscularly for prophylaxis of COVID-19 infection.   On 23 Mar 2021, the patient felt like she was having a heart attack and had pressure from chest down to her stomach.   Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The event(s), felt like she was having a heart attack and had pressure from chest down to her stomach, was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
pt got the first dose of pfizer, waited in the pharmacy waiting area for 15 minutes. When asked if he was feeling good, he responded yes. Pt got up to leave and decided he needed to sit down. His wife stated he felt short of air and couldn't breathe. He threw up in a plastic sack, we called for the Ambulance, the pt stated he was short of air and I had an Epi pen ready
small rash at injection site on 7th day, with severe itchiness radiating all the way down the arm to hand, the rash quadrupled in size by next day, with continued severe itchiness radiating all the way down to hand, and rash  still large and severe itchiness on 9th day. There is still pain at injection site and a sensation of warm with mild swelling. Treated with hydrocortisone crème and Neosporim but no real benefit from those treatments.
18hr pain/redness/swelling @ site (2-4diameter);24hr severe muscle aches, t104.8;dx cellulitis started Ceflex sx more severe (4"-6"_;48hr cellulitis @ site 8"+ diameter;sx cont;72hr t101.2 started pred;muscle aches severe, site-blacki
having seizures that were uncontrollable; This case was reported by a consumer via interactive digital media and described the occurrence of seizure in a 21-year-old female patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   On an unknown date, the patient received Meningococcal B vaccine. On an unknown date, 4 months after receiving Meningococcal B vaccine, the patient experienced seizure (serious criteria death and GSK medically significant). On an unknown date, the outcome of the seizure was fatal. The reported cause of death was seizure.   It was unknown if the reporter considered the seizure to be related to Meningococcal B vaccine.  Additional details were provided as follows:  The age at vaccination was reported. The patient was only 21 years old. The patient received Meningococcal B vaccine and after 4 months experienced horrible seizures and was died in sleep. The patient did not had seizures before. The reporter mentioned that,  she continued having seizures and were uncontrollable.; Reported Cause(s) of Death: Seizure